Effects of raloxifene on the mammary epithelium of female rats in persistent estrus

Gynecological Endocrinology

Volumn 25, Issue 6, 2009, Pages 357-361

  Nogueira, Ludmila T ^a   Da Silva, Benedito B ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Breast; Chemoprevention; Persistent estrus; Raloxifene; Rat; SERMs

Indexed keywords

RALOXIFENE; TESTOSTERONE PROPIONATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; DRUG EFFECT; ESTRUS; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE STRUCTURE; WISTAR HANNOVER RAT;

ANIMALS; EPITHELIUM; ESTROUS CYCLE; FEMALE; MAMMARY GLANDS, ANIMAL; RALOXIFENE; RATS; RATS, WISTAR; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 70350593988     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590802617788     Document Type: Article

References (30)

1. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, et al. Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 1998;90:1371-1388.
2. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation. JAMA 1999;281:2189-2197.
3. Osborne MP. Breast cancer prevention by antiestrogens. Ann N Y Acad Sci 1999;889:146-151.
4. De Lima GR, Facina G, Shida JY, Chein MB, Tanaka P, Dardes RC, Jordan VC, Gebrim LH. Effects of low dose tamoxifen on normal breast tissue from premenopausal women. Eur J Cancer 2003;39:891-898.
5. Martino S, Cauley JA, Barrett-Connor E, Powles TJ, Mershon J, Disch D, Secrest RJ, Cummings SR; CORE Investigators. Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 2004;96:1751-1761.
6. Da Silva BB, Lopes IM, Gebrim LH. Effects of raloxifene on normal breast tissue from premenopausal women. Breast Cancer Res Treat 2006;95:99-103.
7. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL III, Robidoux A, Margolese RG, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA 2006;295:2727-2741.
8. Da Silva BB, Gebrim LH, Simõ Es MJ, Baracat EC, Rodrigues de Lima G. Morphologic and morphometric study of the breast parenchyma of rats in persistent estrus treated with tamoxifen and conjugated estrogens. Clin Exp Obstet Gynecol 2001;28:60-62.
9. da Silva BB, Lopes-Costa PV, Rosal MA, Pires CG, dos Santos LG, Gontijo JA, Alencar AP, de Jesus Simões M. Morphological and morphometric analysis of the adrenal cortex of androgenized rats. Gynecol Obstet Invest 2007;64:44-48.
10. Barraclough CA. Production of anovulatory, sterile rats by single injections of testosterone propionate. Endocrinology 1961;68:62-67.
11. Gorski RA, Wagner JW. Gonadal activity and sexual differentiation of the hypothalamus. Endocrinology 1965;76:226-239.
12. Harris GW, Levine S. Sexual differentiation of the brain and its experimental control. J Physiol 1965;181:379-400.
13. Wrenn TR, Wood JR, Bitman J. Oestrogen responses of rats neonatally sterilized with steroids. J Endocrinol 1969;45:415-420.
14. Da Silva BB, Rocha Gontijo JA, Crete AR, De Jesus Simoes M. Evaluation of body weight in androgenized female rats. Clin Exp Obstet Gynecol 2002;29:97-99.
15. Harvey JA, Santen RJ, Petroni GR, Bovbjerg VE, Smolkin ME, Sheriff FS, Russo J. Histologic charges in the breast with menopausal hormonal hormone therapy use; correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices. Menopause 2008;15: 67-73.
16. Masson P. Tumeurs humaines. Histologie diagnostics et techniques, 2nd ed. Paris: Libraire Maloine; 1956. pp 1061- 1148.
17. Weibel ER, Gomez DM. A principle for counting structures on random sections. J Appl Physiol 1962;17:343-348.
18. Grady D, Ettinger B, Moscarelli E, Plouffe L Jr, Sarkar S, Ciaccia A, Cummings S. Multiple outcomes of raloxifene evaluation investigators. Safety and adverse effects associated with raloxifene: Multiple outcomes of raloxifene evaluation. Obstet Gynecol 2004;104:837-844.
19. Lien EA, Solheim E, Ueland PM. Distribution of tamoxifen and its metabolites in rat and human tissues during steadystate treatment. Cancer Res 1991;51:4837-4844.
20. Hascalik S, Celik O, Tamser M, Mizrak B. Effects of resveratrol, raloxifene, tibolone and conjugated equine estrogen on vaginal squamous cell maturation of ovariectomized rats. Gynecol Obstet Invest 2005;60:186-191.
21. Czerny B, Teister M, Juzyszyn Z, Kamiń ski A, Pawlik A. Effect of tamoxifen and raloxifene on the conjugation of bile acids with taurine and glycine in ovariectomized rats. Pharmacol Rep 2006;58:435-438.
22. De Deus JM, Girão MJ, Sartori MG, Baracat EC, Rodrigues De Lima G, Nader HB, Dietrich CP. Glycosaminoglycan profile in bladder and urethra of castrated rats treated with estrogen, progestogen, and raloxifene. Am J Obstet Gynecol 2003;189:1654-1659.
23. Jacobsohn D, Norgen A. Early effects of testosterone propionate injected into 5 day old rats. Acta Endocrinol (Copenh) 1965;49:453-465.
24. Jordan VC. An overview of considerations for testing of tamoxifeno as a preventive for breast cancer. Ann N Y Acad Sci 1995;768:141-147.
25. Da Silva BB, Da Silva RG Jr, Borges US, Da Silveira FMA, Pimentel IC, Gebrim LH, Simõ es Mde J, Baracat EC. Quantificationm of angiogenesis induced in rabbit cornea by breast carcinoma of women treated with tamoxifen. J Surg Oncol 2005;90:77-80.
26. Liu H, Park WC, Bentrem DJ, McKian KP, Reyes Ade L, Loweth JA, Schafer JM, Zapf JW, Jordan VC. Structure- function relationships of the raloxifene-estrogen receptoralpha complex for regulating transforming growth factor-alpha expression in breast cancer cells. J Biol Chem 2002;277:9189-9198.
27. Jordan VC. Effect of tamoxifeno (ICI 46474) on initiation and growth of DMBA - Induced rat mammary carcinomata. Eur J Cancer 1976;12:419-424.
28. Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999;140:5566-5578.
29. Saji S, Sakaguchi H, Andersson S, Warner M, Gustafsson J. Quantitative analysis of estrogen receptor proteins in rat mammary gland. Endocrinology 2001;142:3177-3186.
30. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahistrom T, Coombes RC, Warner M, et al. Estrogen receptor beta in breast cancer. Endocr Relat Cancer 2002;9:1-13. (Pubitemid 34302928)